sorry...copy and pasted the wrong part of the rticle, although its all relevant.Gilead & Forty Seven
Further cementing Gilead’s ambitions in cancer, this $4.9 billion deal adds an antibody targeting several blood cancers to the company’s research pipeline.
Forty Seven is based in Menlo Park, a short drive away from Gilead’s base in Foster City, and is developing magrolimab, which is targeting myelodysplastic syndrome (MDS), acute myeloid leukaemia (AML), and diffuse large B-cell lymphoma (DLBCL).
A potential first-in-class therapy, magrolimab targets CD47, which produces a “do not eat me” signal that allows cancer cells to avoid destruction (an area AbbVie has almost invested significantly in).
By targeting CD47 it’s hoped that magrolimab will allow the patient’s own innate system to engulf and eradicate cancer cells.
The company presented promising results from a phase 1b study of magrolimab in patients with MDS and AML at the American Society of Hematology meeting in December.
- Forums
- ASX - By Stock
- Media Thread
sorry...copy and pasted the wrong part of the rticle, although...
- There are more pages in this discussion • 11,998 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $768.4M |
Open | High | Low | Value | Volume |
10.5¢ | 10.8¢ | 10.0¢ | $746.7K | 7.120M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
176 | 10004604 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 420568 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
176 | 10004604 | 0.100 |
12 | 525784 | 0.099 |
10 | 716843 | 0.098 |
11 | 640958 | 0.097 |
10 | 772491 | 0.096 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 420568 | 8 |
0.110 | 7967553 | 66 |
0.115 | 6445983 | 53 |
0.120 | 11666760 | 87 |
0.125 | 13968032 | 53 |
Last trade - 16.10pm 28/03/2024 (20 minute delay) ? |
|
|||||
Last
10.3¢ |
  |
Change
0.000 ( 2.40 %) |
|||
Open | High | Low | Volume | ||
10.3¢ | 10.5¢ | 10.3¢ | 1930285 | ||
Last updated 15.59pm 28/03/2024 ? |
Featured News
IMU (ASX) Chart |
The Watchlist
BGD
BARTON GOLD HOLDINGS LIMITED
Alex Scanlon, Managing Director & CEO
Alex Scanlon
Managing Director & CEO
SPONSORED BY The Market Online